LUHUA WANG to Infusions, Intravenous
This is a "connection" page, showing publications LUHUA WANG has written about Infusions, Intravenous.
Connection Strength
0.013
-
High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine. J Clin Oncol. 2005 Oct 01; 23(28):7013-23.
Score: 0.013